Nisa Investment Advisors, LLC Solid Biosciences Inc. Transaction History

Nisa Investment Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$1.69 - $2.46 $11,492 - $16,728	-6,800 Closed	0 $0
Q1 2021 Apr 26, 2021	SELL	$5.37 - $10.72 $8,055 - $16,080	-1,500 Reduced 18.07%	6,800 $38,000
Q4 2020 Jan 25, 2021	SELL	$3.08 - $7.79 $2,464 - $6,232	-800 Reduced 8.79%	8,300 $63,000
Q2 2020 Jul 27, 2020	BUY	$2.1 - $3.42 $17,430 - $28,386	8,300 Added 1037.5%	9,100 $27,000
Q4 2019 Jan 17, 2020	BUY	$2.82 - $12.9 $2,256 - $10,320	800 New	800 $4,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $29.8M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nisa Investment Advisors, LLC with notifications on news.